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ABSTRAK
Antibiotik profilaksis dapat mencegah ILO (Infeksi Luka Operasi) sampai < 5 % ada pasien yang menjalani kraniotomi. Fosfomycin
memiliki spektrum aktivitas untuk semua patogen rentan menyebabkan ILO pada kraniotomi (Staphylooccus aureus dan
Staphylococcus epidermidis) dan memiliki kemampuan untuk menembus ke dalam CSF dengan atau tanpa kondisi inflamasi pada
mninges (rasio fosfomycin AUCCSF/AUCs, tanpa peradangan, adalah 0,09-0,27). Sebuah studi prospektif observasional dilakukan
untuk menganalisis efektivitas fosfomycin dalam mencegah infeksi Luka Operasi (ILO) pasca prosedur kraniotomi pada unit gawat
darurat RS Pendidikan Dr. Soetomo Surabaya dengan insiden SSI sebagai parameter (superficial, deep atau organ). Kriteria inklusi
adalah pasien dengan cedera otak tertutup (ringan, sedang, atau berat), menjalani prosedur kraniotomi tanpa implan, menerima
fosfomycin sebagai antibiotik profilaksis (2 x 2 g iv dalam 30-60 menit sebelum operasi bedah), dan 30 hari setelah prosedur
kraniotomi luka operasi dievaluasi. Ada 30 pasien yang diperoleh dari penelitian ini. Insiden ILO pada pasien dengan abses
subdural (dikategorikan sebagai ILO organ) adalah 3,3%. Faktor risiko yang kebanyakan ditemukan pada pasien dengan ILO
adalah riwayat merokok 30 hari sebelum prosedur bedah, meminum obat immunosuppressant, menjalani operasi darurat, durasi
operasi > 3,75 jam dan pendarahan Volume ≥ 1500 mL. Bakteri yang menyebabkan ILO adalah Pseudomonas aeruginosa yang
sensitif terhadap fosfomycin, piperasilin tazobactam, dan meropenem. LOS pasien dengan ILO 3x lebih lama daripada tanpa ILO.
Fosfomycin efektif mencegah ILO pada pasien dengan prosedur postcraniotomy cedera otak tertutup pada unit gawat darurat RS
Pendidikan Dr. Soetomo Surabaya.(FMI 2014;50:153-159)
Kata kunci: cedera otak tertutup, kraniotomi, infeksi luka operasi, fosfomisin
ABSTRACT
Prophylactic antibiotics can prevent SSI (Surgical Site Infection) until < 5% in patients undergo craniotomy. Fosfomycin has
spectrum of activity for all susceptible pathogens of SSI in craniotomy (Staphylococcus aureus and Staphylococcus epidermidis) and
has the ability to penetrate into CSF with or without inflammation condition of meninges (fosfomycin AUCCSF/AUCs ratio, without
inflammation, is 0.09–0.27). An observasional prospective study was conducted to analyze the effectiveness of fosfomycin in
preventing surgical site infection (SSI) post craniotomy procedure at emergency unit of Dr. Soetomo Teaching Hospital Surabaya
with incidents of SSI as the parameters (superficial, deep or organ). Inclusion criteria were patients with closed brain injury (mild,
moderate, or severe), underwent craniotomy procedure without implant, received fosfomycin as prophylactic antibiotic (2 x 2 g iv
within 30–60 minutes prior surgical operation), and 30 days after craniotomy procedure, the surgical sites were evaluated. There
were 30 patients obtained from this study. The incidence of SSI in patients with subdural abcess (categorized as organ SSI) was
3,3%. Risk factor found mostly in patient with SSI were smoking history 30 days before surgical procedure, taking
immunosuppressant agents, undergo emergency surgery, operating duration > 3,75 hours and bleeding volume ≥ 1500 mL. Bacteria
causing SSI was Pseudomonas aeruginosa which is sensitive to fosfomycin, piperacillin tazobactam, and meropenem. LOS patient
with SSI 3x longer than without SSI. Fosfomycin effectively prevented SSI in patients with closed brain injury postcraniotomy
procedure at emergency unit of Dr. Soetomo Teaching Hospital Surabaya. (FMI 2014;50:153-159)
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INTRODUCTION
Brain injury remains a serious problem in Indonesia,
particularly in hospitals Dr. Soetomo (Wahyuadi et al
2007, Wahyuhadi 2010). The high mortality rate in
patients with brain injury caused by intracranial
hematoma formation can be prevented with hematoma
evacuation via craniotomy. The most common
complications in brain injury surgery is surgical site
infection (SSI). Although craniotomy include into clean
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surgery (SSI risk is relatively low, ie 0.8 to 5.1%), but
morbidity and mortality remain high due to the SSI
(Kanji & Devlin 2008). SSI organs associated with
increased length of stay (LOS) and higher maintenance
costs when compared with the SSI superficial and SSI
deep.
Clean surgery performed in an emergency can increase
the risk of the SSI into 1.3 to 10.1% (Kanji & Devlin
2008). It is associated with an increased probability of
risk factors associated with SSI intrinsic and extrinsic
factor (Erman et al 2005, Britt et al 2007, Anderson et al
2008). Therefore, prophylactic antibiotics necessary in
clean surgery brain injury patients to prevent SSI
(Barker 2007, Kanji & Devlin 2008).
Figure 1. Chemical Structure of Fosfomycin (Sweetman
2009).
Fosfomycin has a spectrum of activity against
Staphylococcus aureus and Staphylococcus epidermidis
(Rodríguez et al 1985, Gatermann et al 1989, Sweetman
2009). Bacteria maps and antimicrobial sensitivity
patterns RSUS Dr. Soetomo period January to June
2010 showed that fosfomycin against Staphylococcus
aureus has a sensitivity of 89.5% and against
Staphylococcus coagulase negative amounted to 62.5%.
Fosfomycin works by inhibiting the cytoplasm enzyme
uridine diphosphate-Nacetylglucosamine (UDP-
GlcNAc) enolpyruvyl transferase (MurA) so that
inhibiting the early stages of bacterial cell wall synthesis
(intracellular). Most of the fosfomycin molecule
composer groups is hydrophilic, include: epoxy,
phosphate, and hydroxyl. Although fosfomycin is
hydrophilic, fosfomycin has a small molecular size (138
Da) and drug binding with plasma proteins is low
(2.16%). This caused fosfomycin has a relatively high
penetration into the CSF (without inflammatory
conditions 9-27%) (Katzung et al 2009, Patrick 2009,
Sweetman 2009, Nau et al 2010). This study was a
prospective observational study aimed to analyze the
effectiveness of fosfomycin to prevent surgical site
infections in patients with closed brain injury after
craniotomy in IRD Dr. Soetomo hospital with SSI event
parameters (either superficial, deep, or organ).
MATERIALS AND METHODS
This study is a prospective observational study to
observe the development of surgical site condition of 30
closed brain injury patients who have undergone
craniotomy. Studies conducted in the Emergency Room
(IRD), F operating room, also neurosurgery department
of Dr. Soetomo. Inclusion criteria for this study were:
patients with a diagnosis of closed brain injury (brain
injury mild, moderate, or severe), underwent
craniotomy surgery without implant placement, and got
a dose of prophylactic antibiotics fosfomycin 2 x 2 g iv
drip for 30-60 minutes (repetition of the dose when the
operation is performed > 4 hours or bleeding volume
1500 mL). This study has been approved/conduct
ethical clearance by the Health Research Ethics
Committee of Dr. Soetomo hospital over tested research
methods (Ethical Eligibility No.159/Panke. KKE/VII/
2012) dated July 10, 2012.
Closed brain injury patients in IRD Dr. Soetomo
hospital who comply the inclusion criteria were
evaluated their surgical site [includes clinical conditions
(temperature, inflammation), radiological (X-rays, or
CT scan), or microbiological (culture results and
antibiotic sensitivity test)] for 30 days after the
craniotomy. SSI diagnosis performed by surgeons or
physicians, which includes: superficial SSI (involving
layers of skin and subcutaneous tissue), deep SSI
(involving aponeurotica, Loose connective tissue, and
pericranium), SSI organs (involving skull and deeper
organ) the type of the SSI criteria according to the
National nosocomial Infections Surveillance (NNIS)
Systems and SSI-type specific criteria according to the
Centers for Disease Control and Prevention
(CDC)/National Healthcare Safety Network (NHSN).
The recorded data were patient's demographic data,
surgical conditions, prophylactic antibiotics usage data,
the use of other antibiotics, and evaluation of the
surgical site. The obtained data then processed into
tables and diagrams form.
RESULTS
During the study period (August 2012 to January 2013)
obtained 36 patients who suitable with the inclusion
criteria. A total of 6 patients dropped out (4 patients
died without undergoing surgical site infection prior to
30 days after craniotomy surgery and 2 patients
withdrew from the study because choosing outpatient
health authority that closer to patients' home so the
development of the site surgery cannot be followed).
Patients who dropped out were not included in the
analysis. Therefore, the total number of samples in this
study was 30 patients.
Based on gender classification, we obtained 19 male
and 11 female, male dominate by 63% compared to
37% female patients. The age distribution of patients
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between 11-76 years (29.2), the most was range of 18-
64 years (57%). The most brain injury type was
moderate brain injury with 17 patients (57%), while
mild brain injury patients was 8 patients (26%), and
patients with severe brain injury was the smallest type
of brain injury with 5 patients (17%) (Table 1).
There was one patient experienced SSI (3,3%). SSI that
happening was subdural abscess (including SSI organs)
(Figure 2).
Figure 2. Evaluation of Patient’s Site Surgical
Development
SSI occurred in patient that received fosfomycin with
duration of 1 day (figure 3).
Figure 3. Fosfomycin Usage Duration & SSI Incident
Table 2 showed presurgical (related with patient) and
perisurgical (related with surgical procedure) patient’s
risk factor (related to patient).
Table 3 contains number of risk factors per patient data
associated with the occurrence of the ILO. There were 4
patients (13%) with no risk factors. While most risk
factors, namely the number 5 risk factors contained in 1
patient (3%). Twenty other patients have varying risk
factors, namely the 15 patients (50%) with 1 risk factor,
5 patients (17%) with 2 risk factors, and 5 patients
(17%) with 3 risk factors. Surgical site infection (ILO)
only occurred in patients with the highest risk factors.
These five risk factors is as listed in Table 3.
Table 4 contains microbiological data, include ILO-
causing bacteria and antibiotic sensitivity profile.
Culture performed on day 21 days post surgery.
Table 1. Patients' characteristics based on age, sex, and
brain injury
Demographic Data Patient Number (n=30) Percentage (%)
Gender
Male 19 63
Female 11 37
Age
< 18 years 12 40
18-64 years 17 57
≥ 65 years 1 3
Brain Injury Type
Mild 8 26
Moderate 17 57
Severe 5 17
Table 2. Patients' intrinsic/preoperative and extrinsic/perioperative risk factors
Risk Factor Data Patient(n=30) Note
Presurgical Risk Factor
Obesitas (BMI ≥ 30)
BMI < 30 30
BMI ≥ 30 0
Obesity patients require increased
prophylactic antibiotic dose
Smoking  history 30 days presurgical
Smoking 4
Didn’t smoking 26
Smoking can block wound healing process,
so smoking should be stopped 30 days
before operation
Perisurgical Risk Factor
Immunosupresant Drug
Use 6
Didn’t use 24
Immunosuppressant administration in
perioperative period should be avoided (if
possible)
Surgical Characteristic
Cito/emergency (≤ 4 hours from admission hour) 22
Urgent (4-24 hours from admission hour) 7
Electif (> 24 jam hours from admission hour) 1
Operation in emergency condition
increases the risk of ILO
Fosfomycin Usage Duration
1 Day 1
Prophylactic antibiotic can be provided
maximally 24 hours after operation
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> 1 day 29
Surgical Duration
≤ 3,75 hours 16
> 3,75hours 14
Craniotomy > 3.75 hours increases the risk
of ILO
Bleeding Volume (mL)
< 1500 mL 27
≥ 1500 mL 3
Prophylactic antibiotic administration is
suggested if bleeding occurs in a volume of
≥ 1500 mL
Drainase  Installation Duration
≤ 5 days 30
> 5 days 0
Drainase  Installation > 5 5 days increase
SSI risk factor
ICP monitor Installation Duration
≤ 5 days 2
> 5 days 0
ICP monitor Installation > 5 days increase
SSI risk factor
Tabel 3. Total patients' risk factors and ILO incidence
Risk factor numbers(*) Patient (n=30) ILO incidence
No risk factor 4 0
1 15 0
2 4 0
3 6 0
4 0 0
5 1 1 (3.3%)
Note: The risk factors intended include: smoking history 30 days
preoperatively, use of immunosuppressants, undergoing cito/
emergency operation, duration of operation > 3.75 hours, and bleeding
volume of ≥ 15 mL. (*) total risk factors 2 indicate that the patients
have 2 out of 5 ILO risk factors, for example: undergoing
cito/emergency operation and duration of operation > 3.75 hours.
Tabel 4. Microbiological data on ILO-causing bacteria
and antibiotic sensitivity profiles
Data Hasil
Material Pus from operation wound
Bacteria Pseudomonas aeruginosa
Antibiotic sensitivity profile
Sensitive Fosfomisin
Piperacillin tazobactam
Meropenem
Intermediate Aztreonam
Resistant Amikacin
Gentamycin
Tobramycin
Ceftazidim
Ciprofloxacin
Levofloxacin
Ticarcillin-Clavulanic Acid
Table 5. Data on Length of Stay (LOS)
LOS Data Brain Injury Type MRS 1 MRS 2 Total
Without SSI Mild
Moderate
Severe
4-11 days
6-26 days
8-31 days
-
-
-
4-11 days
6-26 days
8-31 days
SSI Mild 6 days 27 days 33 days
Note: MRS1 is hospitalization due to brain injury that lead the patient to
undergo craniotomy. MRS2 was hospitalization due to ILO experienced by the
patients that lead them to undergo operation for abscess excision and forehead
flap.
The patient's condition when diagnosed SSI, namely:
normal WBC (7,68.103 μ/L), normal temperature (37.1
°C), dizziness, GCS 456, the site open and pus on
surgical site, and the results of the CT scan which
indicate the presence of a mass in the subdural area. The
patient subsequently underwent inpatient with empiric
therapy ceftriaxon 2 x 1g (iv) and metronidazole 3 x 500
mg (iv) for 6 days. Culture results came out on day 7
with bacteria and sensitivity (table 4), so 3 x 1g
meropenem as an antibiotic definitive was given.
Meropenem was given for 9 days. Patients undergoing
surgery exciseon abscess and fore head flap on day 13.
Improved patient outcomes after therapy with normal
WBC (7,31.103 μ/L), normal temperature (36.5 °C),
reduced complaints of dizziness, GCS 456, and the
condition of the surgical site without open site and pus
were negative.
LOS distribution in patients without SSI was 4-31 days
(11 days). In patients without SSI, patient's LOS severe
brain injury > moderate brain injury > mild brain injury.
While LOS in patients with SSI were 33 days (6 days at
the time of the first MRS and 27 days during the second
MRS). LOS patients with SSI 3x longer LOS than
patients without SSI (with the same diagnosis, ie mild
brain injury) (Table 5).
DISCUSSION
From the results of the evaluation of the surgical site
samples of 30 patients during 30 days showed that the
SSI events occurred in 1 patient (3.3%). The aim of
prophylactic antibiotics usage was to prevent the SSI
(Bratzler et al 2013). Antibiotic prophylaxis was
effective when it can prevent surgical site infections to
< 5% in Patients who experienced a clean surgical
(craniotomy). Other studies have also shown that
antibiotic prophylaxis in craniotomy prevent the SSI
effectively even in patients with low risk, which can
lower the SSI from 10.0% to 4.6% (p < 0.0001)
(Korinek et al 2005). Therefore, the percentage
incidence of SSI obtained 3.3% in this study, showed
that Fosfomycin prevent surgical site infections
effectively in patient with closed brain injury after
craniotomy in IRD Dr. Soetomo hospital.
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There were 4 patients with a smoking history prior to
surgery in this study, and one of them suffered SSI.
Nicotine contained in cigarettes, can delay site healing
and increase the risk of the SSI (Mangram et al 1999).
Smoking can decrease blood circulation to the skin
through microvascular obstruction of platelet
aggregation and increase hemoglobin that was not
functioning properly. Therefore, stop smoking 30 days
before surgery is recommended (level A II) in an effort
to prevent the occurrence of the SSI (Anderson et al
2008).
In this study, there were 6 patients receiving immune-
suppressant drugs (dexamethason) and one of them
suffered the SSI. Dexamethason with a dose of 4 mg
administered as therapy to cope with allergic reactions
(pruritus, urticaria) due to PRC transfusion while being
treated at the IRD and Surgical Irna F. Chemotherapy or
other immunosuppressant drugs can suppress the
immune system. Steroids or other immunosuppressant
drugs given in the perioperative period predisposes to
the SSI. SSI occurred significantly more frequently in
patients who received preoperative steroids (12.5%)
than those without steroids (6.7%). However, in another
study states that there is no relationship between the use
of steroids with risk ILO (Mangram et al 1999).
Therefore, if possible, immunosuppressant drugs should
not be given in the perioperative period (recommend-
ation level C II) (Anderson et al 2008).
Looking from the surgical characteristic, there were 22
patients who underwent emergency surgery in this study
and one of them suffered SSI. Clean surgical performed
in an emergency can increase the risk of the SSI into 1.3
to 10.1%. It is associated with an increased likelihood of
risk factors associated with the SSI (Kanji & Devlin
2008). On clean surgical with emergency conditions
(21.05%) was significantly higher than the SSI on
elective surgery (7.61%) (p = 0.002) (Mahesh et al
2010). Risk factors for infection were higher in all
categories, both preoperative and perioperative if
surgery was performed in an emergency (emergency).
In this study, there were 14 patients who underwent
surgery with a duration of > 3.75 hours, and one of them
suffered the SSI. Cut points for the duration of the
operation were the 75th percentile of the distribution of
the duration of the operation of national NHSN
database. Duration of surgery higher than the cut-point
lead to a higher risk. According to the NHSN report in
2009, the cut point for craniotomy was 225 minutes
(3.75 hours). Duration of surgery> cut point is one
component of NHSN risk index. The average incidence
of SSI on clean surgical increased significantly with
increasing duration of surgery (p = 0.018) (Mahesh et al
2010). Other SSI risk factors were including obesity and
cutting hair (bald). In this study, no patients were obese.
Obesity was defined by a BMI ≥ 30 kg/m2, was one of
the risk factors of the SSI (Mangram et al 1999).
Increasing the dose antibiotic prophylaxis was
recommended (level A II) in obese patients (Anderson
et al 2008).
Culture performed on day 21 of post surgery days with
pus material from the surgical site. Bacteria found was
Pseudomonas aeruginosa. Prospective study on 418
patients who followed their operation site, showed that
Pseudomonas aeruginosa (26%) is the second most
bacteria SSI after Staphylococcus aureus (34%)
(Mahesh et al 2010). Study in neurosurgical showed that
Pseudomonas aeruginosa was one of the causes of the
SSI (10%). Prospective observational study in Kuala
Lumpur on 30 patients with post-craniotomy SSI
showed that Staphylococcus aureus (36%), MRSA
(17%), Pseudomonas aeruginosa was the causes of the
SSI (13%).
Subdural abscess SSI that occurred in this study led to
high LOS on SSI patient. In patients without SSI, the
LOS of patients severe brain injury (8-31 days) >
moderate brain injury (6-26 days) > mild brain injury
(4-11 days). While LOS in patients with SSI (mild brain
injury) of 33 days (6 days at the time of the first MRS
and 27 days during the second MRS). LOS patients with
SSI 3x longer LOS than patients without SSI (with the
same diagnosis, ie mild brain injury). The first MRS
was the MRS brain injury so patients underwent
craniotomy surgery, while second MRS was due SSI so
patients undergoing surgery excise abscess and fore
head flap. When compared with the superficial SSI and
deep SSI, organs SSI associated with increased LOS
and higher maintenance costs. Retrospective study of
103 patients post craniotomy showed that LOS in
patients with SSI (an average of 58 days with a range of
10-154 days) was significantly higher than LOS patients
without SSI (average of 15 days with a range of 2-76
days (p < 0.001) (Cha et al 2010). Systematic review of
3 studies on the relationship between the SSI with LOS,
showed an increase in LOS (post-surgery) for 5-18
days.
Based on the bacteria map and antimicrobial
susceptibility in Dr. Soetomo hospital period January-
June 2010 fosfomycin have known that a relatively high
sensitivity, good against Staphylococcus aureus
(89.5%), as well as against Staphylococcus coagulase
negative (62.5%). When compared with bacteria map
and antimicrobial susceptibility in Dr. Soetomo hospital
period from July to December 2012 at Surgery Ward,
can be seen a decrease in the sensitivity of fosfomycin
against Staphylococcus aureus (60%) against Staphylo-
coccus coagulase negative and (12%). This shows the
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changing patterns of antimicrobial susceptibility in Dr.
Soetomo hospital can be caused due to the use of
fosfomycin as prophylactic antibiotics.
Antibiotic prophylaxis recommended by Kanji & Devlin
(2008) was sefazolin or cefotaxime 1g 1 x 1 x 1 g, or
trimethoprim-sulfamethoxazol 1 x 160/800 mg iv when
patients with penicillin allergy (level IA) with the
possibility of SSI causing pathogens are Staphylococcus
aureus and Staphylococcus epidermidis. Antibiotic
Prophylaxis in Surgery 2012 recommended sefazolin as
antibiotic prophylaxis in clean neurosurgical with the
same pathogen causes the SSI. For patients who were
allergic to penicillin, clindamycin was recommended.
Sefazolin also recommended as antibiotic prophylaxis in
clean neurosurgical with alternative antibiotics
clindamycin or vancomycin in patients allergic to β-
lactams. Restricted vancomycin occurred only in
patients with MRSA colonization (levels I- III/A) (Kanji
& Devlin 2008, Bratzler et al 2013). Based on the
guidelines above, it can be seen that the recommended
antibiotic prophylaxis in clean neurosurgical operations
were sefazolin, cefotaxime, or if the patient is allergic to
penicillin can be used sulfamethoxazol-trimethoprim,
clindamycin, or vancomycin. However, preparations of
clindamycin and trimethoprim-sulfamethoxazol by
administering parenteral route was not available in
Indonesia. While the usage of vancomycin was
restricted only in patients with MRSA colonization.
Penetration of antibiotics into the CSF depends on the
characteristic of their pharmacokinetic. Central nervous
compartment surrounded by at least one layer of cells
consisting of two membrane lipids mostly bound form
tight junctions) so that the overall CNS seen surrounded
by a lipid layer. Therefore, the lipophilicity of the
compounds increase its penetration into the CNS
membranes. Based on molecular structure, sefazolin and
cefotaxime were lipophilic, while the fosfomycin was
hydrophilic. The antibiotic lipophilicity looked from the
group that composes the molecule. Most of the
constituent groups of sefazolin were lipophilic
molecules, namely: methyl, thiometil, thiadiazol,
tetrazol-1 -ylacetamido, and cephem. Hydrophilic group
only carboxylic. Most of the constituent groups of
cefotaxime were also lipophilic molecules, namely:
asetoksimetil, aminothiazol, methoxyimino acetamido
and cephem. Hydrophilic group was only carboxylic.
While on fosfomycin, most of the molecule wa
hydrophilic constituent groups, include: epoxy,
phosphate, and hydroxyl. Although fosfomycin was
hydrophilic, fosfomycin has a small molecular size and
binding of drugs to plasma proteins was low. This leads
to fosfomycin has a relatively high penetration into the
CSF. The entry of the compound into the CSF is
inversely proportional to the square root of the
molecular mass. The smaller the mass of the molecule,
compound penetration into the CSF is easier (Nau et al
2010). Fosfomycin has a smaller molecular mass (138
Da), when compared with sefazolin (450 Da) and
cefotaxime (455 Da). Ties of drugs to plasma proteins
(mainly albumin or globulin) resulting in low drug
penetration into the CSF. Fosfomycin bonds with
plasma proteins (2.16%) lower than sefazolin (85%) and
cefotaxime (40%). t ½ sefazolin equal to fosfomycin,
which was 1.8 hours, while the cefotaxime was shorter,
1.5 hours. Sefazolin and cefotaxime is a weak acid with
a pH that is almost the same, sefazolin 4.0-6.0;
cefotaxime 4.5-6.5, whereas fosfomycin is a weak base
with a pH of 6.5 to 8.5. With the above pharmaco-
kinetics, causing CSF penetration of fosfomycin
(without inflammatory conditions 9-27%) higher than
sefazolin (inflammatory conditions 1-4%) and
cefotaxime (at the 12% condition without inflammation,
the inflammatory condition of 4-17%) (Katzung et al
2009, Patrick 2009, Sweetman 2009, Nau et al 2010).
However, the usage of antibiotic fosfomycin was
restricted in Dr. Soetomo hospital. Thus as an
alternative to craniotomy prophylaxis in patients with
closed brain injury can conducted study using
prophylactic antibiotics such on guidelines of
prophylactic antibiotics, such as cefotaxime.
CONCLUSION
Fosfomycin effectively prevent surgical site infection
(SSI) in patients with closed brain injury after
craniotomy in IRD Dr. Soetomo hospital with SSI
percentage of 3.3%. SSI-causing bacteria are
Pseudomonas aeruginosa. Antibiotics that sensitive
against to bacteriaare fosfomycin, Piperacillin
tazobactam, and meropenem. LOS of patients with SSI
3x longer than without SSI.
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